SS
Stephen L Silvestro
Chief Executive Officer

Stephen L Silvestro insider trades: OptimizeRx (OPRX) stock buys and sales

Chief Executive Officer, OptimizeRx Last trade Oct 3, 2025 32 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2021
1
Company
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Stephen reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Oct 3, 2025OPRX↓ Sell$30K
Aug 16, 2022OPRX↑ Buy$50K
Dec 17, 2021OPRX↓ Sell$727K
Nov 17, 2021OPRX↓ Sell$980K
Oct 18, 2021OPRX↓ Sell$1.1M
Sep 17, 2021OPRX↓ Sell$924K
Aug 17, 2021OPRX↓ Sell$773K
Jul 20, 2021OPRX↓ Sell$667K
Jun 17, 2021OPRX↓ Sell$708K
May 17, 2021OPRX↓ Sell$566K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other OPRX insiders

Open-market trades in the last 12 months

About Stephen L Silvestro's insider trades

Stephen L Silvestro is Chief Executive Officer at OptimizeRx (OPRX). Since May 17, 2021, Stephen has reported 1 open-market purchase worth $50K and 9 sales worth $6.5M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include option exercises (17 filings), shares withheld for taxes (11 filings), grants and awards (11 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every OPRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.